UF Health MedEd Cast

In this episode, we dive into the importance of bone health for patients undergoing spinal surgery, emphasizing how osteoporosis can impact surgical outcomes. We explore the benefits of establishing a bone health clinic where endocrinologists and spinal neurosurgeons collaborate to provide comprehensive care, improving both bone strength and recovery. Tune in to learn how better bone quality can lead to enhanced surgical success and long-term healing.

In this episode, Drs. Friedman and Bova help listeners understand the radiosurgery paradigm, discuss the kinds of tumors that can be treated with radiosurgery, and explain the role that UF Health has played in the development of radiosurgery.

Preventing Overuse Injuries: What Parents Need to KnowThis episode dives into the critical issue of overuse injuries in adolescent baseball pitchers. Dr. Ryan Roach discusses key risk factors, the importance of proper mechanics, and actionable advice for parents and coaches to help keep young athletes safe.

In this episode, Drs. Beaver and Xiang provide an introduction of new treatment options for IST: Inappropriate Sinus Tachycardia. 

The panelists review common conditions leading to pediatric intestinal failure. They will also discuss the importance of multidisciplinary care that children receive as patients of the UF Pediatric Intestinal Rehabilitation Program.

In this interview, Drs. Scali and Spratt discuss how the historical norms are being challenged for connective tissue disease patients (CTD) and endovascular repair.

Untreated obstructive sleep apnea in children can be associated with growth, developmental, and cardiopulmonary complications. Surgical options to treat OSA in children are constantly evolving, from not only new techniques on the traditional adenotonsillectomy to newer surgical techniques in older children.

In this podcast, Tarik Benidir, M.D., a urologic oncologist at UF Health, argues that focal therapy is revolutionizing the treatment of prostate cancer. He emphasizes the importance of patient selection criteria, potential risks and benefits, and optimal treatment pathways. Stay ahead of the curve with the latest updates on focal therapy techniques, such as cryotherapy, HIFU, and irreversible electroporation, showcasing how they can change patient experiences and treatment results.

In this episode, Drs. Konecny and Syed discuss state of the art treatments of sleep apnea and heart disease at UF Health, including identifying high rates of sleep apnea in patients with cardiovascular disease, understanding the difference between obstructive sleep apnea and central sleep apnea, identifying the limitations of traditional treatments for sleep apnea in cardiovascular patients, the phrenic nerve stimulator as an alternative treatment for central sleep apnea, and the collaboration between sleep medicine and cardiology to lead to successful treatment.

In this episode, Drs. Ataya and Justice provide an overview of diagnostic criteria, workup evaluations, and medical treatment, including surgical options, for HHT nosebleeds. They also discuss future direction of HHT research and treatment options.

In this interview, Dr. Norrell provides key information about children with neuromuscular disorders, such as cerebral palsy, spina bifida, hereditary spastic paraplegia, chromosomal disorders, and children with gait abnormalities, such as toe-walking. This is great content for physical therapists, primary care physicians and neurologists who may be interested in having their patients evaluated for improved coordination and optimization of care.

Dr. Austin Lam identifies considerations to employ when assessing reconstructive options for aerodigestive tract defects and other soft tissue defects within the head and neck, describing advantages and drawbacks of various commonly employed free tissue options and how to select the most ideal free flap for a given defect.

Cardiac amyloidosis used to be a disease with no treatment and poor outcomes. Now we have new treatment options, new ways to make the diagnosis, and much improved outcomes. Unfortunately, this disease is still very under-diagnosed, often until patients are in the late stages of the disease. Dr. Parker shares a brief update on how cardiac amyloidosis develops, and how it's diagnosed and treated in the modern era.

Jonahtan Wright, MD reviews the effect of smoking on functional outcomes and implant survival of anatomical total shoulder arthroplasty. He and his team sought to compare functional outcomes and survival between non-smokers, former smokers, and current smokers who underwent anatomical total shoulder arthroplasty (aTSA) in a large cohort of patients. Our study suggests that smoking has a negative effect on aTSA functional outcomes that may persist even after quitting.

We discuss some of the main urologic goals for our pediatric patients with spina bifida. In addition to different treatment options and management considerations, we address the importance of multidisciplinary care.

Thomas Schrepfer, M.D., discusses what sialendoscopy is, how it works as a minimally invasive technique, and the benefits and limitations in treating salivary gland disorders.

Salvatore Scali, MD, provides a contemporary perspective on aortic surgery training will be discussed highlighting current case volumes and future projections among training programs in the United States. The barriers to open aortic surgical training and potential opportunities that are available to offset these challenges longitudinally will be discussed.

ECPR is a treatment option for patients who otherwise would face near-certain death. It involves the use of a machine that temporarily takes over the function of the heart and lung.

Jeffrey Friedman, MD, FACS, FASMBS, discusses gastroparesis, a challenging condition where the stomach's delayed emptying triggers discomforting symptoms like nausea, vomiting, bloating, and abdominal pain. He explores how precise diagnostic tests and a range of treatment options, from dietary changes to advanced surgical solutions, can offer relief and improve quality of life.

Elias Sayour, M.D., discusses the challenges of creating therapeutic cancer vaccines, advantages for mRNA vaccines and how to adapt mRNA to treat patients with cancer.

Dr. Maryam Rahman shares insight on the role of laser ablation in the treatment of brain tumors.

1. Review bronchiolitis pathophysiology and epidemiology.2. Discuss the 2014 clinical guidelines on bronchiolitis.3. Describe de-implementation strategies and projects related to bronchiolitis management.

1. Gain updated information on the current status of hemophilia gene therapy.2. Understand the limitations of the first generation of AAV vectors currently in use. 3. Learn about the strategies being developed to mitigate those limitations.

As a result of participation in this activity, participants should be able to:1. Understand the current HPV-related cancer epidemic: concerning trends, novel treatments, outcomes.2. Describe the current status of smoking-related head and neck cancer: prevalence, new risks, state of the art treatments and outcomes3. Counsel a patient on head and neck cancer prevention and outcomes of treatment.Q&A:Which risk factor(s) for head and neck cancer is becoming more dominant over time?A) SmokingB) Smoking and Alcohol ConsumptionC) Human Papilloma Virus (HPV)D) Dental Infections ANSWER: C Head and neck cancer is often thought of as a “visible cancer” that patients cannot hide from after treatment. Why is that?A) Treatment often effects how patients look (cosmesis)B) Treatment often leads to deficits in speech which makes it difficult to interact with othersC) The cancers and their treatment often cause swallowing dysfunction, making it challenging to eat and drink in publicD) Side effects of treatment change how a patient functions in everyday life including work, socializing and basic daily activitiesE) All of the aboveANSWER: E How has reconstructive surgery advanced in the last 30 years to improve functional outcomes?A) Through the use of plastic implantsB) Laser technologyC) Better stitching techniquesD) The use of free tissue transfer (free flap) to rebuilding missing structures and organs ANSWER: D

1. Understand the ways to screen for T1D risk (Autoantibodies).2. Be aware of the currently FDA approved therapies to prevent/delay T1D progression.3. Refer potential subjects for participation in T1D research studies.**please add the below exam questions for CE credits: 1. More than 90% of newly diagnosed patients with type 1 diabetes do NOT have a first degree family member with type 1 diabetes (T/F) - answer True2. Type 1 diabetes can be delayed with the use of an FDA approved immunotherapy (T/F) - answer True3. Which autoantibodies can be used to detect T1DGADAIAAIA2AZnT8AICAAnswer - all of the above

As a result of participation in this activity, participants should be able to:1. Describe the presentation of chronic venous insufficiency, and identify which patients require referral to vascular surgery.2. Distinguish chronic venous insufficiency from other causes of leg pain and leg swelling.3. Recognize the unique pathophysiology of Post-thrombotic Syndrome.

Dr. Nicole Iovine and Dr. Philip Efrom discuss Sepsis, including medical terminology, pathophysiology, risk factors, and its critical implications within the medical field.

Dr. Nicole Iovine and Dr. Philip Efrom discuss Sepsis, including medical terminology, pathophysiology, risk factors, and its critical implications within the medical field.

As a result of participation in this activity, participants should be able to: 1. Acquire proficiency in the assessment and evaluation of patients who present with symptoms suggestive of uterine myomas, recognizing the key clinical features and using appropriate diagnostic tools to confirm the diagnosis. 2. Tailor the diagnostic workup and approach for different patient populations with uterine myomas, understanding the influence of factors such as age, fertility status, and comorbidities on the clinical presentation and prognosis of the condition. 3. Adopt a patient-centered approach to managing patients with uterine myomas, considering the array of available therapeutic options, their suitability to the individual patient's needs and circumstances, and the potential complications and outcomes of each intervention.

As a result of participation in this activity, participants should be able to:1. understand the basic concepts of MEG technology and its underlying principles, and describe the advantages of MEG compared to other neuroimaging techniques, such as functional magnetic resonance imaging (fMRI) and electroencephalography (EEG). 2. define and describe clinical and research applications of MEG in patients with neurological diseases, including epilepsy, brain tumors, Alzheimer's disease, and Parkinson disease3. highlight the potential future directions for MEG research and clinical applications, including its use in non-invasive brain-computer interfaces

Anna Khanna MD.and Brian Hoh MD, MBA, FACS, FAHA, FAANS describe treatment options and the importance of timely treatment for acute ischemic stroke. In this podcast, they outline the benefits of mobile stroke units. Additionally, they explain the research that has been conducted surrounding MSTU's across the country how they can decrease stroke related disability and improve outcomes for stroke patients.

Elias Sayour, MD, PhD highlights the signs and symptoms of pediatric brain tumors. He explains how they are classified and discusses current management strategies. Additionally, he shares the challenges of treating brain tumors in children and for developing effective therapies and limitations of brain tumor clinical trials to find new treatments.

At the University of Florida Division of Gastroenterology, Hepatology & Nutrition, the team constantly expand their knowledge to provide minimally invasive procedures that can save patients' lives. In this podcast, Bashar Qumseya MD, MPH, FASGE highlights the typical and atypical presentation of GERD, the sequala of untreated acid reflux and exciting recent advances to management of patients with chronic GERD.

At the University of Florida Division of Gastroenterology, Hepatology & Nutrition, the team constantly expand their knowledge to provide minimally invasive procedures that can save patients' lives. In this podcast, Bashar Qumseya MD, MPH, FASGE highlights endoscopic sleeve gastroplasty, a non-surgical approach to management of obesity. He describes the increasing prevalence of obesity, talks about the sequala of untreated obesity and outlines recent advances to management of patients with obesity

Ashley Ghiaseddin, M.D., highlights treatment strategies for malignant gliomas. He shares challenges to therapeutic options, the standard approaches to treatment, novel treatment strategies and when it is important to refer to the specialists at UF Health Shands Hospital.

William A. Friedman M.D., describes the diagnostic criteria for trigeminal neuralgia as well as other facial pain disorders. He highlights the best medical therapy for trigeminal neuralgia and its limitations and he outlines the three neurosurgical options for treating medically refractory trigeminal neuralgia.

R. James Toussaint M.D. discusses lateral ankle sprains, the prevalence of these injuries and the mechanics involved. He explains the difference between mechanical instability vs functional instability, when nonoperative and operative treatment are indicated and importantly, the return to play criteria for an ankle sprain during recovery phase and functional phase.

As a result of participation in this activity, participants should be able to:1. Describe the basics of BPH and Holmium laser enucleation of the prostate2. Explain the appropriate evaluation and patient selection for Holmium laser enucleation of the prostate3. Outline the Pro's and Con's of Holmium laser enucleation of the prostate

Aaron Franke M.D., M.S highlights current challenges facing the shifting paradigm of early-stage NSCLC management. He analyzes recent data supporting novel therapeutic approaches vs standard of care in resectable NSCLC. He reviews anticipated and ongoing clinical trials using IO-based therapy in early-stage NSCLC. Additionally, he examines knowledge gaps and challenges facing adopting the neoadjuvant paradigm in clinical practice as he helps us to understand clinical parameters that qualify patients for ICI-based neoadjuvant therapy and he highlights how to plan therapy for patients with stage I-III NSCLC based on individual patient considerations, expert recommendations, and available clinical data.

Si Chen M.D. discusses cochlear implants and expanding access to hearing rehabilitation. She highlights the limitations of hearing aids and when cochlear implants should be considered. She describes cochlear implant evaluation, surgery, post-operative care, and hearing outcomes and she shares recent advances and ongoing research that are improving cochlear implant performance

Oluwadamilola Oladeru M.D. discusses prone position for breast radiation treatment. She describes the benefits of prone positioning for protecting normal tissues including lungs and heart. She examines recent studies regarding prone position and she shares the factors that make a patient a good candidate for prone position or breast cancer radiation treatment.

Oluwadamilola Oladeru M.D. discusses patient-centered breast radiotherapy fractionation and treatment approach. She describes the changing trend of radiotherapy fractionation over the last 20 years and the long-term results of UK FAST and FAST FORWARD studies. Lastly she describes the patient selection for short course treatment and its benefits in terms of patient convenience.

As a result of participation in this activity, participants should be able to:1. Describe the most common causes of nasal obstruction.2. Outline the initial treatment protocol that should be prescribed.3.Discuss when referral to ENT and surgical intervention may be helpful.

Drs. Calvin Choi and Mohammad Al-Ani discuss the epidemiology and symptoms associated with hypertrophic cardiomyopathy (HCM), the contemporary evaluation and management strategy for HCM, and the latest advances in treatment options for HCM.

Robert Zlotecki M.D., PhD describes the factors that make a patient a candidate for Pluvicto treatment for prostate cancer. He explains the process of treatment through a series of Pluvicto infusions for prostate cancer and he outlines the current shift in thinking regarding systemic radiopharmaceutical therapy for prostate cancer.